Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pentanal | HCID 8063 | — |
| Reactant | Sodium | HCID 5360545 | — |
| Reactant | HCID 59349461 | HCID 59349461 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 178476262 | HCID 178476262 | — |
Reaction Steps
A round-bottom flask was charged with pentanal (0.177 g, 2.0 mmol) and N4-(5-bromo-2-methylphenyl)-N5-(6-(piperazin-1-yl)-1H-benzo[d]imidazol-2-yl)-1H-imidazole-4,5-dicarboxamide (0.104 g 0.2 mmol), anhydrous DMF (5 mL) and sodium triacetoxybrohydride (0.212 g, 1.0 mmol). The reaction mixture was stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure and subsequently purified by preparative reverse phase HPLC (ammonium acetate/acetonitrile) to give N4-(5-bromo-2-methylphenyl)-N5-[5-(4-pentylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-imidazole-4,5-dicarboxamide acetate. 1H-NMR (400 MHz, DMSO-d6): δ 8.09 (s, 1H), 7.99 (d, 1H), 7.39 (dd, 1H), 7.29-7.3 (m, 2H), 6.87 (dd, 1H), 3.07 (t, 4H), 2.31 (t, 7H), 1.91 (s, 2H), 1.43-1.50 (m, 2H), 1.23-1.34 (m, 4H), 0.90 (t, 3H), MS (EI): 594.8 (MH+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08088767B2 |
|---|
| Source dataset | uspto-grants-2012_01 |
|---|
| ORD ID | ord-78cbc35e8358424abc33c0841496f63b |
|---|
| Source note | uspto-grants-2012_01 |
|---|